Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apellis Pharmaceuticals Inc COM | 3,006,980 | 3,006,980 | 0 | $86.72M | $95.95M | 16.32% | +$9.23M |
| ArriVent BioPharma, Inc.(AVBP) | 1,976,387 | 2,059,387 | +83,000 | $46.45M | $54.86M | 9.33% | +$8.42M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,746,667 | 2,110,167 | +363,500 | $47.82M | $46.00M | 7.82% | -$1.82M |
| Centessa Pharmaceuticals PlcADS | 2,012,052 | 1,993,052 | -19,000 | $32.17M | $33.38M | 5.68% | +$1.21M |
| Verona Pharma PlcADS | 1,835,200 | 571,264 | -1,263,936 | $52.80M | $26.53M | 4.51% | -$26.27M |
| Nuvation Bio Inc.CL A(NUVB) | 12,171,513 | 9,202,907 | -2,968,606 | $27.87M | $24.48M | 4.16% | -$3.39M |
| Insmed Incorporated(INSM) | 436,820 | 332,000 | -104,820 | $31.89M | $22.92M | 3.90% | -$8.97M |
| Cogent Biosciences, Inc.(COGT) | 1,305,000 | 2,763,000 | +1,458,000 | $14.09M | $21.55M | 3.67% | +$7.46M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 488,000 | +488,000 | $0 | $21.09M | 3.59% | +$21.09M |
| Mind Medicine Mindmed Inc | 3,018,000 | 3,018,000 | 0 | $17.17M | $21.01M | 3.57% | +$3.83M |
| Ocular Therapeutix, Inc.(OCUL) | 2,425,000 | 2,425,000 | 0 | $21.10M | $20.71M | 3.52% | -$388.0K |
| Taysha Gene Therapies, Inc.(TSHA) | 4,572,222 | 10,450,000 | +5,877,778 | $9.19M | $18.08M | 3.08% | +$8.89M |
| Viridian Therapeutics, Inc.(VRDN) | 870,000 | 870,000 | 0 | $19.79M | $16.68M | 2.84% | -$3.11M |
| Gossamer Bio, Inc.(GOSS) | 9,187,883 | 18,350,000 | +9,162,117 | $9.06M | $16.60M | 2.82% | +$7.54M |
| Dyne Therapeutics, Inc.(DYN) | 262,726 | 668,000 | +405,274 | $9.44M | $15.74M | 2.68% | +$6.30M |
| Pharvaris N V COM | 620,470 | 778,000 | +157,530 | $11.49M | $14.91M | 2.54% | +$3.42M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 1,115,000 | 1,115,000 | 0 | $23.00M | $13.16M | 2.24% | -$9.85M |
| Merus N V | 0 | 308,000 | +308,000 | $0 | $12.95M | 2.20% | +$12.95M |
| Erasca, Inc.(ERAS) | 0 | 5,136,795 | +5,136,795 | $0 | $12.89M | 2.19% | +$12.89M |
| BridgeBio Pharma, Inc.(BBIO) | 552,000 | 441,600 | -110,400 | $14.05M | $12.12M | 2.06% | -$1.94M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 904,000 | +904,000 | $0 | $11.95M | 2.03% | +$11.95M |
| Kalvista Pharmaceuticals Inc | 0 | 1,370,000 | +1,370,000 | $0 | $11.60M | 1.97% | +$11.60M |
| Unicycive Therapeutics Inc | 8,559,000 | 10,000,000 | +1,441,000 | $3.49M | $7.94M | 1.35% | +$4.45M |
| Regulus Therapeutics Inc | 4,263,701 | 4,848,802 | +585,101 | $6.69M | $7.66M | 1.30% | +$967.1K |
| Perspective Therapeutics, Inc.(CATX) | 1,422,224 | 2,304,752 | +882,528 | $18.99M | $7.35M | 1.25% | -$11.63M |
| Neurogene Inc.(NGNE) | 15,000 | 303,000 | +288,000 | $629.4K | $6.93M | 1.18% | +$6.30M |
| Allovir Inc | 0 | 11,215,000 | +11,215,000 | $0 | $4.71M | 0.80% | +$4.71M |
| Atyr Pharma Inc | 0 | 900,000 | +900,000 | $0 | $3.26M | 0.55% | +$3.26M |
| Helix Acquisition Corp IiCL A | 250,000 | 250,000 | 0 | $2.61M | $2.63M | 0.45% | +$12.5K |
| Mersana Therapeutics Inc | 992,000 | 992,000 | 0 | $1.87M | $1.42M | 0.24% | -$456.3K |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 312,336 | 312,336 | 0 | $715.2K | $830.8K | 0.14% | +$115.6K |
| Aerovate Therapeutics Inc | 465,440 | 0 | -465,440 | $972.8K | $0 | — | -$972.8K |
| Allovir Inc | 11,202,000 | 0 | -11,202,000 | $9.06M | $0 | — | -$9.06M |
| Annexon, Inc.(ANNX) | 400,000 | 0 | -400,000 | $2.37M | $0 | — | -$2.37M |
| Autolus Therapeutics plcADS(AUTL) | 176,000 | 0 | -176,000 | $638.9K | $0 | — | -$638.9K |
| Black Diamond Therapeutics I | 594,000 | 0 | -594,000 | $2.58M | $0 | — | -$2.58M |
| Century Therapeutics, Inc.(IPSC) | 666,825 | 0 | -666,825 | $1.14M | $0 | — | -$1.14M |
| Cybin D/B/A Helus Pharma(HELP) | 489,596 | 0 | -489,596 | $4.35M | $0 | — | -$4.35M |
| EyePoint, Inc.(EYPT) | 1,093,503 | 0 | -1,093,503 | $8.74M | $0 | — | -$8.74M |
| Mineralys Therapeutics, Inc.(MLYS) | 600,000 | 0 | -600,000 | $7.27M | $0 | — | -$7.27M |
| Nkarta, Inc.(NKTX) | 120,000 | 0 | -120,000 | $542.4K | $0 | — | -$542.4K |
| PepGen Inc.(PEPG) | 376,117 | 0 | -376,117 | $3.22M | $0 | — | -$3.22M |
| Praxis Precision Medicines, Inc.(PRAX) | 130,000 | 0 | -130,000 | $7.48M | $0 | — | -$7.48M |
| Rapt Therapeutics Inc | 292,000 | 0 | -292,000 | $586.9K | $0 | — | -$586.9K |
| Reneo Pharmaceuticals Inc | 2,250,000 | 0 | -2,250,000 | $3.83M | $0 | — | -$3.83M |
| Structure Therapeutics IncADS | 1,198,000 | 0 | -1,198,000 | $52.58M | $0 | — | -$52.58M |
| Tenaya Therapeutics, Inc.(TNYA) | 2,576,200 | 0 | -2,576,200 | $4.97M | $0 | — | -$4.97M |
| Ventyx Biosciences Inc | 2,391,114 | 0 | -2,391,114 | $5.21M | $0 | — | -$5.21M |